Verotoxigenic Escherichia coli: costs of illness in Canada, including long-term health outcomes.

摘要: The main objective of this study was to provide cost estimates human Escherichia coli O157 infection facilitate future assessment the benefits and costs alternative preventive strategies reduce illness. We investigated illness Canadians from primary by verotoxigenic E. (also called Shiga toxin–producing O157) using data National Notifiable Diseases Registry. used relative risk information peer-reviewed publications estimate burden associated for eight long-term health outcomes. number cases (mean 5th 95th percentiles), costs, a rank correlation test identify which outcomes were with highest per capita calculated. An estimated 22,344 infections occur in Canada annually, costing $26.7 million. There are 37,867 additional on-going $377.2 million each year. Our analysis i...